This information was published on 2026-03-02T12:26:02 for IP Right Filed Published.
| Field | Value |
| (210) | 2631816 |
| (220) |
02 Mar 2026
|
| (300) |
GB, 05 Sep 2025, UK00004260051
|
| (511) (510) |
Class 9
Downloadable software for patient advocacy purposes; Downloadable software for collecting, monitoring, analyzing, managing, processing, sharing and accessing patient health, medical, diagnostic, and healthcare data; electronic downloadable publications in the fields of healthcare and patient advocacy; downloadable software for providing information in the fields of healthcare and patient advocacy Class 35 Business information services in the fields of healthcare and patient advocacy; provision of business, marketing, product sales and commercial information relating to pharmaceutical, medical and healthcare products via a global communications network; retail, wholesale, and online retail store services in connection with the sale of healthcare products; distribution of advertising, marketing and promotional material in the fields of healthcare and patient advocacy; data analysis in the fields of healthcare and patient advocacy Class 41 Educational services, namely, conducting programs in the fields of healthcare and patient advocacy, and distribution of educational materials in connection therewith Class 42 Design and development of computer software in the fields of healthcare and patient advocacy; providing online non-downloadable software for collecting, monitoring, analyzing, managing, processing, sharing and accessing patient health, medical, diagnostic, and healthcare data; providing online non-downloadable software for providing information in the fields of healthcare and patient advocacy Class 45 Providing patient advocacy services in the fields of healthcare and health management; healthcare advocacy services for patients and their families regarding the coordination of medical services |
| (540) | SOLACE |
| (550) | Word |
| (730) |
Find Solace, Inc.
|
| (750) |
Ashurst Australia
|
Find out more about publications on the About page.